Subscribe in a readerFollica has raised money to begin a human trial of its hair cloning technology. According to the company’s website, the company has obtained “an exclusive, worldwide license from the University of Pennsylvania to develop and commercialise a breakthrough technology that has been demonstrated to stimulate the genesis and development of new follicles.” It is announced it had completed a $5.5 million Series A financing round.
